Topic

Solutions Services Director, Remarque Systems

Articles

DCTs can be a great tool for small-to-midsize pharma and biotech companies despite misconceptions of them being advantageous for only Big Pharma.

Unraveling DCT Misconceptions

Patients reap benefits of strong collaboration in executing DCTs.

The DCT Network: When Experienced Providers Come Together, We Can Revolutionize Clinical Research

How DCTs can impact pharmaceutical companies exploring DTx 
combination products and standalone DTx studies.

Digital Therapeutics and Decentralized Trials: A Match Made in Clinical

As market factors drive the rapid growth of decentralized clinical trials, organizations should embrace risk-based quality management to evaluate the new dimensions of risk and ensure effective oversight of disparate data sources, writes John Hall.

Achieving Successful Decentralized Trials by Leveraging RBQM and Centralized Monitoring Oversight 

Industry provides endless methods in crafting solutions for patients.

How One CRO Uses RBQM in DCT Implementation

Vice President, Digital and Decentralized Solutions, PPD Clinical Research Services, Thermo Fisher Scientific

DCTs proving to solve numerous pain points for patients in clinical research.

Decentralized Clinical Trials Bring Research to the Patient—in More Ways Than One

VP of Connected Health Technology Solutions, ICON

COVID-19 forces sponsors to take new approach for assessing trial support models.

Identifying Integrated Digital Platforms Designed for a Decentralized Future

Portable imaging technology presents yet another opportunity for decentralized trials.

Role of Healthcare Providers Expands in DCTs

Vice President, Vault CDMS, Veeva Systems

Without a strategy for managing clinical data centrally, sponsors lack the visibility needed to optimize trial outcomes.

Data First: Building a Foundation for Digital and Decentralized Clinical Trials

New era of technology brings unique obstacles.

Trial Design